The risks of androgen treatment in postmenopausal women remain controversial: a need for equitable comparisons.
Pru
James K
JK
D000279:Administration, Cutaneous; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D004967:Estrogens / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008252:Macaca fascicularis; D008321:Mammary Glands, Animal / Q000187:drug effects; D042361:Mammary Glands, Human / Q000187:drug effects*; D008593:Menopause; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism
D000728:Androgens; D004967:Estrogens; D013739:Testosterone